Clinical trials
Injection clinical trials
Below are recruiting injection clinical trials, each written for real people, not researchers. We’re tracking 2,041 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07545265RecruitingPhase 1/Phase 2
SKB565 injection for advanced solid cancers
This study tests SKB565, a new injectable cancer treatment, in people with advanced solid tumors (cancer that has spread or hasn't responded to standard treatments). The trial aims to find the right dose and learn how well it works.
Guangzhou, GuangdongAges 18–75 - NCT06684327RecruitingPhase 2
Study of three chemotherapy drugs for rare advanced cancers
This trial tests a combination of three chemotherapy drugs (albumin-paclitaxel, ifosfamide, and cisplatin) for people with certain rare cancers that have spread to other parts of the body (stage IV). It looks at how well the treatment works and if it is safe.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07548203Recruiting
Treatments for Dark Spaces Between Teeth
This study tests different ways to fix dark triangular gaps that appear between teeth below the gum line. These gaps can affect how your smile looks and may trap food. The trial will compare treatment options and follow your results over 6 months.
CairoAges 18–50 - NCT07548567Recruiting
Nerve Block to Reduce Pain During Below-Knee Fracture Surgery
This study tests a nerve-blocking injection (numbing medicine around the femoral artery nerve in your groin area) to help reduce pain and blood pressure changes during below-knee fracture surgery when a tourniquet (pressure cuff) is used. The goal is to see if this approach makes surgery more comfortable and safer.
AthensAges 18 years+ - NCT07547605RecruitingPhase 4
Comparing PRP, Steroid, and Combined Injections for Neck and Shoulder Pain
This study tests three different injection treatments for upper trapezius myofascial pain (a specific type of muscle knot in your neck/shoulder area). Researchers will compare platelet-rich plasma (PRP, made from your own blood), a steroid injection, and a combination of both to see which works best for pain relief.
Kyrenia, KeryneiaAges 18–65 - NCT07546435Recruiting
Male experiences with fertility treatment for low sperm quality
This study explores men's experiences undergoing ICSI, a fertility treatment that helps when sperm quality is reduced. Researchers want to understand how the treatment affects you physically and emotionally.
Skive, Midt JyllandAges 18 years+ - NCT06126510RecruitingPhase 2
Study of VG161 for advanced bone and soft tissue sarcoma
This trial tests a new virus-based therapy (VG161) injected directly into tumors for people with advanced bone and soft tissue sarcoma that hasn't responded to other treatments. The goal is to see if the virus can shrink tumors and slow the cancer's growth.
BeijingAges 18–75 - NCT04840355Recruiting
Monitoring safety of sintilimab in Chinese patients
This study carefully tracks how safe sintilimab is for people with cancer in real-world care. It may help your care team understand side effects and risks during treatment.
Beijing, Beijing MunicipalityAges 18–75 - NCT06746480RecruitingPhase 2
Study of VG161 for advanced bile duct cancer
This trial tests a new medicine called VG161 for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that has stopped responding to or could not be tolerated after at least one prior treatment. It is given by injection into the tumor, and the study wants to see if it can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–75 - NCT06359782RecruitingPhase 2
Testing C1-inhibitor for brain bleed after aneurysm
This trial tests a drug called C1-inhibitor (a protein that calms inflammation) given shortly after a bleeding stroke caused by an aneurysm. The goal is to see if it can reduce brain damage and improve recovery.
The Hague, South HollandAges 18 years+ - NCT06363994RecruitingPhase 3
Study of orelabrutinib plus BR for untreated mantle cell lymphoma
This trial tests a new combination of drugs (orelabrutinib plus BR) compared to BR alone for people with newly diagnosed mantle cell lymphoma who have not had treatment before. It may be an option if you are older or not able to have a stem cell transplant.
BeijingAges 60 years+ - NCT07540572RecruitingPhase 1
Testing IDE574 safety and effectiveness in advanced solid tumors
This early-stage trial tests a new drug called IDE574 to see if it is safe and effective in treating advanced cancers that have spread or stopped responding to standard treatments. The trial focuses mainly on hormone-receptor positive breast cancer, but also includes lung, prostate, and colorectal cancers.
Plantation, FloridaAges 18–99 - NCT07537881RecruitingPhase 1/Phase 2
RC288 for solid tumors: a Phase 1/2 safety and effectiveness study
This study tests a new drug called RC288 to treat solid tumors (cancers that form lumps). Researchers want to see if it's safe and how well it works for people whose cancer hasn't responded to other treatments or has returned.
Hunan, ChangshaAges 18–75 - NCT06404905RecruitingPhase 1
Testing BT02 for advanced solid tumors
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
Beijing, BiejingAges 18–75 - NCT06693362RecruitingPhase 1
Stem cell therapy for severe viral pneumonia
This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07532915Recruiting
Two endoscopy methods to prevent stomach vein bleeding
This trial compares two endoscopic (camera-guided) procedures to prevent or treat bleeding from enlarged veins in the stomach. Both approaches aim to stop dangerous bleeding or prevent it from happening in high-risk patients.
Guangzhou, GuangdongAges 18–80 - NCT07530380RecruitingEarly Phase 1
CAR T-cell therapy for treatment-resistant autoimmune hemolytic anemia
This trial tests a new type of cell therapy called UCAR T-cells, which are immune cells engineered to target and destroy the B cells causing your body to attack its own red blood cells. It's designed for patients whose autoimmune hemolytic anemia hasn't responded to at least 3 standard treatments.
HefeiAges 10 years+ - NCT07528105RecruitingEarly Phase 1
CAR-T Cell Therapy for Early-Stage Type 1 Diabetes
This early-stage trial tests a new type of immune cell therapy (CAR-T cells) designed to stop the body's immune system from attacking insulin-producing cells in type 1 diabetes. The goal is to help preserve remaining pancreas function in people with early-stage disease.
ShanghaiAges 18–40 - NCT07531056RecruitingEarly Phase 1
5-Fluorouracil injections with or without freezing for keloid scars
This trial tests two ways to treat keloids (thick, raised scars that grow beyond the original wound): injecting a medication called 5-fluorouracil alone, or combining it with cryotherapy (freezing). The goal is to see which approach works better for reducing pain, itching, and visible scarring.
Chak Four Hundred Fifty-fourAges 18–50 - NCT06756022Recruiting
Dolasetron to prevent nausea from chemo in kids with leukemia
This trial tests if a medicine called dolasetron can prevent chemotherapy-related nausea and vomiting in children with acute lymphoblastic leukemia (ALL). It may help kids feel better during their first round of treatment.
Hefei, AnhuiAges 2–17 - NCT07523217Recruiting
Poly-L-Lactic Acid Treatment for Depressed Acne Scars
This trial tests whether injections of poly-L-lactic acid (a safe, absorbable filler material) can improve the appearance of depressed or pitted acne scars. If it works, it may offer patients a non-surgical way to smooth out and reduce the visibility of these scars.
Zagazig, Sharqia ProvinceAges 18–40 - NCT07520565RecruitingPhase 3
Emergency stroke treatment with BXOS110 within 3 hours
This trial tests whether BXOS110, an experimental injection, can help people recover better after an acute ischemic stroke (a stroke caused by a blood clot) when given within 3 hours of symptom onset. The study compares BXOS110 to a placebo to see if it reduces disability and improves recovery.
Hengshui, HebeiAges 18–85 - NCT07519564RecruitingPhase 1
Study of GB18 Injection for Cancer-Related Weight Loss
This Phase 1 trial tests a new drug called GB18 to help cancer patients who have experienced significant weight loss and muscle wasting—a condition called cancer cachexia. The drug works by targeting a specific protein involved in weight loss, and researchers want to learn if it can help patients regain weight and strength while also being safe.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07523022Enrolling by invitationPhase 4
Fertility Treatments for Low Sperm Count or Quality
This study compares two different hormone treatments to see which one better improves sperm health and increases pregnancy chances in men with low or abnormal sperm. You'll receive either injections or pills designed to boost sperm production.
SzegedAges 18 years+
Hear when a new Injection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for injection?
- Yes. Clin2 currently lists 2,041 recruiting injection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a injection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a injection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.